+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Sale

Infection Surveillance Solution Market by Product, Deployment, End-User - Global Forecast 2025-2030

  • PDF Icon

    Report

  • 195 Pages
  • October 2024
  • Region: Global
  • 360iResearch™
  • ID: 5012974
UP TO OFF until Dec 31st 2024
1h Free Analyst Time
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

The Infection Surveillance Solution Market grew from USD 768.47 million in 2023 to USD 867.99 million in 2024. It is expected to continue growing at a CAGR of 13.36%, reaching USD 1.84 billion by 2030.

Infection Surveillance Solutions encompass a range of technologies and methodologies designed to monitor and analyze infection patterns within healthcare settings to mitigate risks and enhance patient safety. The necessity for these solutions is underscored by increasing infection rates, stringent regulatory frameworks, and the critical need for early detection in outbreak scenarios. Their application is primarily in hospitals, clinics, and long-term care facilities, aiming to reduce healthcare-associated infections (HAIs), streamline reporting processes, and optimize prevention strategies. The end-use scope extends to healthcare administrators, infection control teams, and public health officials. Market growth factors include advancements in artificial intelligence, machine learning, and real-time data analytics, which enhance predictive accuracy and response times. Increasing healthcare expenditure and the integration of electronic health records further propel the market. However, challenges such as high implementation costs, data privacy concerns, and interoperability issues limit market expansion. Notably, the lack of standardized protocols across regions complicates universal application. Current research opportunities lie in developing cross-platform solutions that ensure seamless data integration and interpretation. Innovations in remote monitoring, IoT-based diagnostics, and wearable technology present significant potential. Companies should focus on enhancing user-interface designs to improve accessibility and workflow integration. Additionally, partnerships with technology firms to leverage cutting-edge analytics and cloud computing can offer competitive advantage. The dynamic nature of this market, driven by continuous technological advancements and evolving healthcare demands, suggests a high potential for growth; however, success will depend on addressing the existing challenges. Regulatory compliance, coupled with fostering collaboration between technologists and healthcare professionals, is essential to circumvent barriers. Building scalable and user-friendly solutions will be central to capturing emergent opportunities, emphasizing the need for rigorous R&D alongside strategic market positioning.

Understanding Market Dynamics in the Infection Surveillance Solution Market

The Infection Surveillance Solution Market is rapidly evolving, shaped by dynamic supply and demand trends. These insights provide companies with actionable intelligence to drive investments, develop strategies, and seize emerging opportunities. A comprehensive understanding of market dynamics also helps organizations mitigate political, geographical, technical, social, and economic risks while offering a clearer view of consumer behavior and its effects on manufacturing costs and purchasing decisions.
  • Market Drivers
    • Growing geriatric population coupled with increasing incidences of chronic diseases
    • Increasing prevalence of hospital-acquired infections (HAIs)
    • Rising adoption of antimicrobial stewardship programs
  • Market Restraints
    • High cost associated with the deployment of infection surveillance solutions
  • Market Opportunities
    • Development of fully automated infection surveillance solution systems with the integration of electronic medical records
    • Rapid emergence of cloud based infection surveillance solutions
  • Market Challenges
    • Limited availability of skilled healthcare IT professional

Exploring Porter’s Five Forces for the Infection Surveillance Solution Market

Porter’s Five Forces framework further strengthens the insights of the Infection Surveillance Solution Market, delivering a clear and effective methodology for understanding the competitive landscape. This tool enables companies to evaluate their current competitive standing and explore strategic repositioning by assessing businesses’ power dynamics and market positioning. It is also instrumental in determining the profitability of new ventures, helping companies leverage their strengths, address weaknesses, and avoid potential pitfalls.

Applying PESTLE Analysis to the Infection Surveillance Solution Market

External macro-environmental factors deeply influence the performance of the Infection Surveillance Solution Market, and the PESTLE analysis provides a comprehensive framework for understanding these influences. By examining Political, Economic, Social, Technological, Legal, and Environmental elements, this analysis offers organizations critical insights into potential opportunities and risks. It also helps businesses anticipate changes in regulations, consumer behavior, and economic trends, enabling them to make informed, forward-looking decisions.

Analyzing Market Share in the Infection Surveillance Solution Market

The Infection Surveillance Solution Market share analysis evaluates vendor performance. This analysis provides a clear view of each vendor’s standing in the competitive landscape by comparing key metrics such as revenue, customer base, and other critical factors. Additionally, it highlights market concentration, fragmentation, and trends in consolidation, empowering vendors to make strategic decisions that enhance their market position.

Evaluating Vendor Success with the FPNV Positioning Matrix in the Infection Surveillance Solution Market

The Infection Surveillance Solution Market FPNV Positioning Matrix is crucial in evaluating vendors based on business strategy and product satisfaction levels. By segmenting vendors into four quadrants - Forefront (F), Pathfinder (P), Niche (N), and Vital (V) - this matrix helps users make well-informed decisions that best align with their unique needs and objectives in the market.

Strategic Recommendations for Success in the Infection Surveillance Solution Market

The Infection Surveillance Solution Market strategic analysis is essential for organizations aiming to strengthen their position in the global market. A comprehensive review of resources, capabilities, and performance helps businesses identify opportunities for improvement and growth. This approach empowers companies to navigate challenges in the increasingly competitive landscape, ensuring they capitalize on new opportunities and align with long-term success.

Key Company Profiles

The report delves into recent significant developments in the Infection Surveillance Solution Market, highlighting leading vendors and their innovative profiles. These include 3M Company, Altarum, Baxter International, Inc., Becton, Dickinson and Company, bioMérieux SA, BioVigil Healthcare Systems, Inc., Cardinal Health Inc., CenTrak, Inc., Clinsys, Inc., Conduent, Inc., Datlowe, s.r.o., DNV AS, Ecolab Inc., Gunnebo Entrance Control Ltd., Health Matrix., Ibhar Technologies Pvt Ltd, Inovalon, International Business Machines Corporation, Medexter Healthcare GmbH, Oracle Corporation, PointClickCare, Premier Inc., RLDatix, Securitas Healthcare, LLC., Strategic Solutions Group, Thermo Fisher Scientific Inc., Vecna Technologies, Inc., VigiLanz Corporation, Vitalacy Inc., Vizzia Technologies, and Wolters Kluwer N.V..

Market Segmentation & Coverage

This research report categorizes the Infection Surveillance Solution Market to forecast the revenues and analyze trends in each of the following sub-markets:
  • Product
    • Services
      • Implementation Services
      • Product Support & Maintainnace Services
      • Training & Consulting Services
    • Software
      • Antimicrobial Monitoring & Control
      • Infection Surveillance
        • Laboratory surveillance
        • Surgical surveillance & patient monitoring
      • Outbreak Management
        • Isolation Management
        • Potential Outbreak Alert
      • Staff Health & Compliance
  • Deployment
    • On-Cloud
    • On-Premise
  • End-User
    • Hospital
    • Laboratories
    • Long-Term Care Facility
  • Region
    • Americas
      • Argentina
      • Brazil
      • Canada
      • Mexico
      • United States
        • California
        • Florida
        • Illinois
        • New York
        • Ohio
        • Pennsylvania
        • Texas
    • Asia-Pacific
      • Australia
      • China
      • India
      • Indonesia
      • Japan
      • Malaysia
      • Philippines
      • Singapore
      • South Korea
      • Taiwan
      • Thailand
      • Vietnam
    • Europe, Middle East & Africa
      • Denmark
      • Egypt
      • Finland
      • France
      • Germany
      • Israel
      • Italy
      • Netherlands
      • Nigeria
      • Norway
      • Poland
      • Qatar
      • Russia
      • Saudi Arabia
      • South Africa
      • Spain
      • Sweden
      • Switzerland
      • Turkey
      • United Arab Emirates
      • United Kingdom

The report provides a detailed overview of the market, exploring several key areas:

  1. Market Penetration: A thorough examination of the current market landscape, featuring comprehensive data from leading industry players and analyzing their reach and influence across the market.
  2. Market Development: The report identifies significant growth opportunities in emerging markets and assesses expansion potential within established segments, providing a roadmap for future development.
  3. Market Diversification: In-depth coverage of recent product launches, untapped geographic regions, significant industry developments, and strategic investments reshaping the market landscape.
  4. Competitive Assessment & Intelligence: A detailed analysis of the competitive landscape, covering market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, technological advancements, and innovations in manufacturing by key market players.
  5. Product Development & Innovation: Insight into groundbreaking technologies, R&D efforts, and product innovations that will drive the market in future.

Additionally, the report addresses key questions to assist stakeholders in making informed decisions:

  1. What is the current size of the market, and how is it expected to grow?
  2. Which products, segments, and regions present the most attractive investment opportunities?
  3. What are the prevailing technology trends and regulatory factors influencing the market?
  4. How do top vendors rank regarding market share and competitive positioning?
  5. What revenue sources and strategic opportunities guide vendors' market entry or exit decisions?

Please note: For this report, the purchase of an Enterprise license allows up to ten worldwide users of an organization access to the report

Please note: For this report, the purchase of an Enterprise license allows up to ten worldwide users of an organization access to the report

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
5. Market Insights
5.1. Market Dynamics
5.1.1. Drivers
5.1.1.1. Growing geriatric population coupled with increasing incidences of chronic diseases
5.1.1.2. Increasing prevalence of hospital-acquired infections (HAIs)
5.1.1.3. Rising adoption of antimicrobial stewardship programs
5.1.2. Restraints
5.1.2.1. High cost associated with the deployment of infection surveillance solutions
5.1.3. Opportunities
5.1.3.1. Development of fully automated infection surveillance solution systems with the integration of electronic medical records
5.1.3.2. Rapid emergence of cloud based infection surveillance solutions
5.1.4. Challenges
5.1.4.1. Limited availability of skilled healthcare IT professional
5.2. Market Segmentation Analysis
5.3. Porter’s Five Forces Analysis
5.3.1. Threat of New Entrants
5.3.2. Threat of Substitutes
5.3.3. Bargaining Power of Customers
5.3.4. Bargaining Power of Suppliers
5.3.5. Industry Rivalry
5.4. PESTLE Analysis
5.4.1. Political
5.4.2. Economic
5.4.3. Social
5.4.4. Technological
5.4.5. Legal
5.4.6. Environmental
6. Infection Surveillance Solution Market, by Product
6.1. Introduction
6.2. Services
6.2.1. Implementation Services
6.2.2. Product Support & Maintainnace Services
6.2.3. Training & Consulting Services
6.3. Software
6.3.1. Antimicrobial Monitoring & Control
6.3.2. Infection Surveillance
6.3.2.1. Laboratory surveillance
6.3.2.2. Surgical surveillance & patient monitoring
6.3.3. Outbreak Management
6.3.3.1. Isolation Management
6.3.3.2. Potential Outbreak Alert
6.3.4. Staff Health & Compliance
7. Infection Surveillance Solution Market, by Deployment
7.1. Introduction
7.2. On-Cloud
7.3. On-Premise
8. Infection Surveillance Solution Market, by End-User
8.1. Introduction
8.2. Hospital
8.3. Laboratories
8.4. Long-Term Care Facility
9. Americas Infection Surveillance Solution Market
9.1. Introduction
9.2. Argentina
9.3. Brazil
9.4. Canada
9.5. Mexico
9.6. United States
10. Asia-Pacific Infection Surveillance Solution Market
10.1. Introduction
10.2. Australia
10.3. China
10.4. India
10.5. Indonesia
10.6. Japan
10.7. Malaysia
10.8. Philippines
10.9. Singapore
10.10. South Korea
10.11. Taiwan
10.12. Thailand
10.13. Vietnam
11. Europe, Middle East & Africa Infection Surveillance Solution Market
11.1. Introduction
11.2. Denmark
11.3. Egypt
11.4. Finland
11.5. France
11.6. Germany
11.7. Israel
11.8. Italy
11.9. Netherlands
11.10. Nigeria
11.11. Norway
11.12. Poland
11.13. Qatar
11.14. Russia
11.15. Saudi Arabia
11.16. South Africa
11.17. Spain
11.18. Sweden
11.19. Switzerland
11.20. Turkey
11.21. United Arab Emirates
11.22. United Kingdom
12. Competitive Landscape
12.1. Market Share Analysis, 2023
12.2. FPNV Positioning Matrix, 2023
12.3. Competitive Scenario Analysis
12.3.1. Orbis Protect Acquires Secure Site UK to Further Enhance Their Security Solutions & Service Offering.
12.3.2. West Hartford-Bloomfield Health District Coalition Against Healthcare-Acquired Infections Team Recognized as NACCHO Infection Prevention and Control Champion.
12.3.3. American Firm Named as Sole Supplier For £20m (USD 24.06 Million) Framework.
12.3.4. Foresight Group Invests Additional £1 Million (USD 1.20 Million) from the Midlands Engine Investment Fund into ReadyGo Diagnostics Limited.
12.3.5. RACGP Launches New Infection Prevention and Control Guidelines.
12.3.6. MIT Chemists Develop a Wireless Electronic Lateral Flow Assay Test for Biosensing.
12.3.7. Infection Prevention and Control Online Learning Launched.
12.3.8. Premier Brings PINC AI Clinical Surveillance Technology to Long-Term Care Facilities.
12.3.9. Bitscopic’s Clinical Surveillance Software to be Implemented at VA Los Angeles and VA Las Vegas.
12.4. Strategy Analysis & Recommendation
List of Figures
FIGURE 1. INFECTION SURVEILLANCE SOLUTION MARKET RESEARCH PROCESS
FIGURE 2. INFECTION SURVEILLANCE SOLUTION MARKET SIZE, 2023 VS 2030
FIGURE 3. GLOBAL INFECTION SURVEILLANCE SOLUTION MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 4. GLOBAL INFECTION SURVEILLANCE SOLUTION MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 5. GLOBAL INFECTION SURVEILLANCE SOLUTION MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 6. GLOBAL INFECTION SURVEILLANCE SOLUTION MARKET SIZE, BY PRODUCT, 2023 VS 2030 (%)
FIGURE 7. GLOBAL INFECTION SURVEILLANCE SOLUTION MARKET SIZE, BY PRODUCT, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 8. GLOBAL INFECTION SURVEILLANCE SOLUTION MARKET SIZE, BY DEPLOYMENT, 2023 VS 2030 (%)
FIGURE 9. GLOBAL INFECTION SURVEILLANCE SOLUTION MARKET SIZE, BY DEPLOYMENT, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 10. GLOBAL INFECTION SURVEILLANCE SOLUTION MARKET SIZE, BY END-USER, 2023 VS 2030 (%)
FIGURE 11. GLOBAL INFECTION SURVEILLANCE SOLUTION MARKET SIZE, BY END-USER, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 12. AMERICAS INFECTION SURVEILLANCE SOLUTION MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 13. AMERICAS INFECTION SURVEILLANCE SOLUTION MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 14. UNITED STATES INFECTION SURVEILLANCE SOLUTION MARKET SIZE, BY STATE, 2023 VS 2030 (%)
FIGURE 15. UNITED STATES INFECTION SURVEILLANCE SOLUTION MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 16. ASIA-PACIFIC INFECTION SURVEILLANCE SOLUTION MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 17. ASIA-PACIFIC INFECTION SURVEILLANCE SOLUTION MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 18. EUROPE, MIDDLE EAST & AFRICA INFECTION SURVEILLANCE SOLUTION MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 19. EUROPE, MIDDLE EAST & AFRICA INFECTION SURVEILLANCE SOLUTION MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 20. INFECTION SURVEILLANCE SOLUTION MARKET SHARE, BY KEY PLAYER, 2023
FIGURE 21. INFECTION SURVEILLANCE SOLUTION MARKET, FPNV POSITIONING MATRIX, 2023
List of Tables
TABLE 1. INFECTION SURVEILLANCE SOLUTION MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
TABLE 3. GLOBAL INFECTION SURVEILLANCE SOLUTION MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 4. GLOBAL INFECTION SURVEILLANCE SOLUTION MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
TABLE 5. GLOBAL INFECTION SURVEILLANCE SOLUTION MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 6. INFECTION SURVEILLANCE SOLUTION MARKET DYNAMICS
TABLE 7. GLOBAL INFECTION SURVEILLANCE SOLUTION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 8. GLOBAL INFECTION SURVEILLANCE SOLUTION MARKET SIZE, BY SERVICES, BY REGION, 2018-2030 (USD MILLION)
TABLE 9. GLOBAL INFECTION SURVEILLANCE SOLUTION MARKET SIZE, BY IMPLEMENTATION SERVICES, BY REGION, 2018-2030 (USD MILLION)
TABLE 10. GLOBAL INFECTION SURVEILLANCE SOLUTION MARKET SIZE, BY PRODUCT SUPPORT & MAINTAINNACE SERVICES, BY REGION, 2018-2030 (USD MILLION)
TABLE 11. GLOBAL INFECTION SURVEILLANCE SOLUTION MARKET SIZE, BY TRAINING & CONSULTING SERVICES, BY REGION, 2018-2030 (USD MILLION)
TABLE 12. GLOBAL INFECTION SURVEILLANCE SOLUTION MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 13. GLOBAL INFECTION SURVEILLANCE SOLUTION MARKET SIZE, BY SOFTWARE, BY REGION, 2018-2030 (USD MILLION)
TABLE 14. GLOBAL INFECTION SURVEILLANCE SOLUTION MARKET SIZE, BY ANTIMICROBIAL MONITORING & CONTROL, BY REGION, 2018-2030 (USD MILLION)
TABLE 15. GLOBAL INFECTION SURVEILLANCE SOLUTION MARKET SIZE, BY INFECTION SURVEILLANCE, BY REGION, 2018-2030 (USD MILLION)
TABLE 16. GLOBAL INFECTION SURVEILLANCE SOLUTION MARKET SIZE, BY LABORATORY SURVEILLANCE, BY REGION, 2018-2030 (USD MILLION)
TABLE 17. GLOBAL INFECTION SURVEILLANCE SOLUTION MARKET SIZE, BY SURGICAL SURVEILLANCE & PATIENT MONITORING, BY REGION, 2018-2030 (USD MILLION)
TABLE 18. GLOBAL INFECTION SURVEILLANCE SOLUTION MARKET SIZE, BY INFECTION SURVEILLANCE, 2018-2030 (USD MILLION)
TABLE 19. GLOBAL INFECTION SURVEILLANCE SOLUTION MARKET SIZE, BY OUTBREAK MANAGEMENT, BY REGION, 2018-2030 (USD MILLION)
TABLE 20. GLOBAL INFECTION SURVEILLANCE SOLUTION MARKET SIZE, BY ISOLATION MANAGEMENT, BY REGION, 2018-2030 (USD MILLION)
TABLE 21. GLOBAL INFECTION SURVEILLANCE SOLUTION MARKET SIZE, BY POTENTIAL OUTBREAK ALERT, BY REGION, 2018-2030 (USD MILLION)
TABLE 22. GLOBAL INFECTION SURVEILLANCE SOLUTION MARKET SIZE, BY OUTBREAK MANAGEMENT, 2018-2030 (USD MILLION)
TABLE 23. GLOBAL INFECTION SURVEILLANCE SOLUTION MARKET SIZE, BY STAFF HEALTH & COMPLIANCE, BY REGION, 2018-2030 (USD MILLION)
TABLE 24. GLOBAL INFECTION SURVEILLANCE SOLUTION MARKET SIZE, BY SOFTWARE, 2018-2030 (USD MILLION)
TABLE 25. GLOBAL INFECTION SURVEILLANCE SOLUTION MARKET SIZE, BY DEPLOYMENT, 2018-2030 (USD MILLION)
TABLE 26. GLOBAL INFECTION SURVEILLANCE SOLUTION MARKET SIZE, BY ON-CLOUD, BY REGION, 2018-2030 (USD MILLION)
TABLE 27. GLOBAL INFECTION SURVEILLANCE SOLUTION MARKET SIZE, BY ON-PREMISE, BY REGION, 2018-2030 (USD MILLION)
TABLE 28. GLOBAL INFECTION SURVEILLANCE SOLUTION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 29. GLOBAL INFECTION SURVEILLANCE SOLUTION MARKET SIZE, BY HOSPITAL, BY REGION, 2018-2030 (USD MILLION)
TABLE 30. GLOBAL INFECTION SURVEILLANCE SOLUTION MARKET SIZE, BY LABORATORIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 31. GLOBAL INFECTION SURVEILLANCE SOLUTION MARKET SIZE, BY LONG-TERM CARE FACILITY, BY REGION, 2018-2030 (USD MILLION)
TABLE 32. AMERICAS INFECTION SURVEILLANCE SOLUTION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 33. AMERICAS INFECTION SURVEILLANCE SOLUTION MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 34. AMERICAS INFECTION SURVEILLANCE SOLUTION MARKET SIZE, BY SOFTWARE, 2018-2030 (USD MILLION)
TABLE 35. AMERICAS INFECTION SURVEILLANCE SOLUTION MARKET SIZE, BY INFECTION SURVEILLANCE, 2018-2030 (USD MILLION)
TABLE 36. AMERICAS INFECTION SURVEILLANCE SOLUTION MARKET SIZE, BY OUTBREAK MANAGEMENT, 2018-2030 (USD MILLION)
TABLE 37. AMERICAS INFECTION SURVEILLANCE SOLUTION MARKET SIZE, BY DEPLOYMENT, 2018-2030 (USD MILLION)
TABLE 38. AMERICAS INFECTION SURVEILLANCE SOLUTION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 39. AMERICAS INFECTION SURVEILLANCE SOLUTION MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 40. ARGENTINA INFECTION SURVEILLANCE SOLUTION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 41. ARGENTINA INFECTION SURVEILLANCE SOLUTION MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 42. ARGENTINA INFECTION SURVEILLANCE SOLUTION MARKET SIZE, BY SOFTWARE, 2018-2030 (USD MILLION)
TABLE 43. ARGENTINA INFECTION SURVEILLANCE SOLUTION MARKET SIZE, BY INFECTION SURVEILLANCE, 2018-2030 (USD MILLION)
TABLE 44. ARGENTINA INFECTION SURVEILLANCE SOLUTION MARKET SIZE, BY OUTBREAK MANAGEMENT, 2018-2030 (USD MILLION)
TABLE 45. ARGENTINA INFECTION SURVEILLANCE SOLUTION MARKET SIZE, BY DEPLOYMENT, 2018-2030 (USD MILLION)
TABLE 46. ARGENTINA INFECTION SURVEILLANCE SOLUTION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 47. BRAZIL INFECTION SURVEILLANCE SOLUTION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 48. BRAZIL INFECTION SURVEILLANCE SOLUTION MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 49. BRAZIL INFECTION SURVEILLANCE SOLUTION MARKET SIZE, BY SOFTWARE, 2018-2030 (USD MILLION)
TABLE 50. BRAZIL INFECTION SURVEILLANCE SOLUTION MARKET SIZE, BY INFECTION SURVEILLANCE, 2018-2030 (USD MILLION)
TABLE 51. BRAZIL INFECTION SURVEILLANCE SOLUTION MARKET SIZE, BY OUTBREAK MANAGEMENT, 2018-2030 (USD MILLION)
TABLE 52. BRAZIL INFECTION SURVEILLANCE SOLUTION MARKET SIZE, BY DEPLOYMENT, 2018-2030 (USD MILLION)
TABLE 53. BRAZIL INFECTION SURVEILLANCE SOLUTION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 54. CANADA INFECTION SURVEILLANCE SOLUTION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 55. CANADA INFECTION SURVEILLANCE SOLUTION MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 56. CANADA INFECTION SURVEILLANCE SOLUTION MARKET SIZE, BY SOFTWARE, 2018-2030 (USD MILLION)
TABLE 57. CANADA INFECTION SURVEILLANCE SOLUTION MARKET SIZE, BY INFECTION SURVEILLANCE, 2018-2030 (USD MILLION)
TABLE 58. CANADA INFECTION SURVEILLANCE SOLUTION MARKET SIZE, BY OUTBREAK MANAGEMENT, 2018-2030 (USD MILLION)
TABLE 59. CANADA INFECTION SURVEILLANCE SOLUTION MARKET SIZE, BY DEPLOYMENT, 2018-2030 (USD MILLION)
TABLE 60. CANADA INFECTION SURVEILLANCE SOLUTION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 61. MEXICO INFECTION SURVEILLANCE SOLUTION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 62. MEXICO INFECTION SURVEILLANCE SOLUTION MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 63. MEXICO INFECTION SURVEILLANCE SOLUTION MARKET SIZE, BY SOFTWARE, 2018-2030 (USD MILLION)
TABLE 64. MEXICO INFECTION SURVEILLANCE SOLUTION MARKET SIZE, BY INFECTION SURVEILLANCE, 2018-2030 (USD MILLION)
TABLE 65. MEXICO INFECTION SURVEILLANCE SOLUTION MARKET SIZE, BY OUTBREAK MANAGEMENT, 2018-2030 (USD MILLION)
TABLE 66. MEXICO INFECTION SURVEILLANCE SOLUTION MARKET SIZE, BY DEPLOYMENT, 2018-2030 (USD MILLION)
TABLE 67. MEXICO INFECTION SURVEILLANCE SOLUTION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 68. UNITED STATES INFECTION SURVEILLANCE SOLUTION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 69. UNITED STATES INFECTION SURVEILLANCE SOLUTION MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 70. UNITED STATES INFECTION SURVEILLANCE SOLUTION MARKET SIZE, BY SOFTWARE, 2018-2030 (USD MILLION)
TABLE 71. UNITED STATES INFECTION SURVEILLANCE SOLUTION MARKET SIZE, BY INFECTION SURVEILLANCE, 2018-2030 (USD MILLION)
TABLE 72. UNITED STATES INFECTION SURVEILLANCE SOLUTION MARKET SIZE, BY OUTBREAK MANAGEMENT, 2018-2030 (USD MILLION)
TABLE 73. UNITED STATES INFECTION SURVEILLANCE SOLUTION MARKET SIZE, BY DEPLOYMENT, 2018-2030 (USD MILLION)
TABLE 74. UNITED STATES INFECTION SURVEILLANCE SOLUTION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 75. UNITED STATES INFECTION SURVEILLANCE SOLUTION MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
TABLE 76. ASIA-PACIFIC INFECTION SURVEILLANCE SOLUTION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 77. ASIA-PACIFIC INFECTION SURVEILLANCE SOLUTION MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 78. ASIA-PACIFIC INFECTION SURVEILLANCE SOLUTION MARKET SIZE, BY SOFTWARE, 2018-2030 (USD MILLION)
TABLE 79. ASIA-PACIFIC INFECTION SURVEILLANCE SOLUTION MARKET SIZE, BY INFECTION SURVEILLANCE, 2018-2030 (USD MILLION)
TABLE 80. ASIA-PACIFIC INFECTION SURVEILLANCE SOLUTION MARKET SIZE, BY OUTBREAK MANAGEMENT, 2018-2030 (USD MILLION)
TABLE 81. ASIA-PACIFIC INFECTION SURVEILLANCE SOLUTION MARKET SIZE, BY DEPLOYMENT, 2018-2030 (USD MILLION)
TABLE 82. ASIA-PACIFIC INFECTION SURVEILLANCE SOLUTION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 83. ASIA-PACIFIC INFECTION SURVEILLANCE SOLUTION MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 84. AUSTRALIA INFECTION SURVEILLANCE SOLUTION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 85. AUSTRALIA INFECTION SURVEILLANCE SOLUTION MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 86. AUSTRALIA INFECTION SURVEILLANCE SOLUTION MARKET SIZE, BY SOFTWARE, 2018-2030 (USD MILLION)
TABLE 87. AUSTRALIA INFECTION SURVEILLANCE SOLUTION MARKET SIZE, BY INFECTION SURVEILLANCE, 2018-2030 (USD MILLION)
TABLE 88. AUSTRALIA INFECTION SURVEILLANCE SOLUTION MARKET SIZE, BY OUTBREAK MANAGEMENT, 2018-2030 (USD MILLION)
TABLE 89. AUSTRALIA INFECTION SURVEILLANCE SOLUTION MARKET SIZE, BY DEPLOYMENT, 2018-2030 (USD MILLION)
TABLE 90. AUSTRALIA INFECTION SURVEILLANCE SOLUTION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 91. CHINA INFECTION SURVEILLANCE SOLUTION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 92. CHINA INFECTION SURVEILLANCE SOLUTION MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 93. CHINA INFECTION SURVEILLANCE SOLUTION MARKET SIZE, BY SOFTWARE, 2018-2030 (USD MILLION)
TABLE 94. CHINA INFECTION SURVEILLANCE SOLUTION MARKET SIZE, BY INFECTION SURVEILLANCE, 2018-2030 (USD MILLION)
TABLE 95. CHINA INFECTION SURVEILLANCE SOLUTION MARKET SIZE, BY OUTBREAK MANAGEMENT, 2018-2030 (USD MILLION)
TABLE 96. CHINA INFECTION SURVEILLANCE SOLUTION MARKET SIZE, BY DEPLOYMENT, 2018-2030 (USD MILLION)
TABLE 97. CHINA INFECTION SURVEILLANCE SOLUTION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 98. INDIA INFECTION SURVEILLANCE SOLUTION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 99. INDIA INFECTION SURVEILLANCE SOLUTION MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 100. INDIA INFECTION SURVEILLANCE SOLUTION MARKET SIZE, BY SOFTWARE, 2018-2030 (USD MILLION)
TABLE 101. INDIA INFECTION SURVEILLANCE SOLUTION MARKET SIZE, BY INFECTION SURVEILLANCE, 2018-2030 (USD MILLION)
TABLE 102. INDIA INFECTION SURVEILLANCE SOLUTION MARKET SIZE, BY OUTBREAK MANAGEMENT, 2018-2030 (USD MILLION)
TABLE 103. INDIA INFECTION SURVEILLANCE SOLUTION MARKET SIZE, BY DEPLOYMENT, 2018-2030 (USD MILLION)
TABLE 104. INDIA INFECTION SURVEILLANCE SOLUTION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 105. INDONESIA INFECTION SURVEILLANCE SOLUTION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 106. INDONESIA INFECTION SURVEILLANCE SOLUTION MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 107. INDONESIA INFECTION SURVEILLANCE SOLUTION MARKET SIZE, BY SOFTWARE, 2018-2030 (USD MILLION)
TABLE 108. INDONESIA INFECTION SURVEILLANCE SOLUTION MARKET SIZE, BY INFECTION SURVEILLANCE, 2018-2030 (USD MILLION)
TABLE 109. INDONESIA INFECTION SURVEILLANCE SOLUTION MARKET SIZE, BY OUTBREAK MANAGEMENT, 2018-2030 (USD MILLION)
TABLE 110. INDONESIA INFECTION SURVEILLANCE SOLUTION MARKET SIZE, BY DEPLOYMENT, 2018-2030 (USD MILLION)
TABLE 111. INDONESIA INFECTION SURVEILLANCE SOLUTION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 112. JAPAN INFECTION SURVEILLANCE SOLUTION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 113. JAPAN INFECTION SURVEILLANCE SOLUTION MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 114. JAPAN INFECTION SURVEILLANCE SOLUTION MARKET SIZE, BY SOFTWARE, 2018-2030 (USD MILLION)
TABLE 115. JAPAN INFECTION SURVEILLANCE SOLUTION MARKET SIZE, BY INFECTION SURVEILLANCE, 2018-2030 (USD MILLION)
TABLE 116. JAPAN INFECTION SURVEILLANCE SOLUTION MARKET SIZE, BY OUTBREAK MANAGEMENT, 2018-2030 (USD MILLION)
TABLE 117. JAPAN INFECTION SURVEILLANCE SOLUTION MARKET SIZE, BY DEPLOYMENT, 2018-2030 (USD MILLION)
TABLE 118. JAPAN INFECTION SURVEILLANCE SOLUTION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 119. MALAYSIA INFECTION SURVEILLANCE SOLUTION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 120. MALAYSIA INFECTION SURVEILLANCE SOLUTION MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 121. MALAYSIA INFECTION SURVEILLANCE SOLUTION MARKET SIZE, BY SOFTWARE, 2018-2030 (USD MILLION)
TABLE 122. MALAYSIA INFECTION SURVEILLANCE SOLUTION MARKET SIZE, BY INFECTION SURVEILLANCE, 2018-2030 (USD MILLION)
TABLE 123. MALAYSIA INFECTION SURVEILLANCE SOLUTION MARKET SIZE, BY OUTBREAK MANAGEMENT, 2018-2030 (USD MILLION)
TABLE 124. MALAYSIA INFECTION SURVEILLANCE SOLUTION MARKET SIZE, BY DEPLOYMENT, 2018-2030 (USD MILLION)
TABLE 125. MALAYSIA INFECTION SURVEILLANCE SOLUTION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 126. PHILIPPINES INFECTION SURVEILLANCE SOLUTION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 127. PHILIPPINES INFECTION SURVEILLANCE SOLUTION MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 128. PHILIPPINES INFECTION SURVEILLANCE SOLUTION MARKET SIZE, BY SOFTWARE, 2018-2030 (USD MILLION)
TABLE 129. PHILIPPINES INFECTION SURVEILLANCE SOLUTION MARKET SIZE, BY INFECTION SURVEILLANCE, 2018-2030 (USD MILLION)
TABLE 130. PHILIPPINES INFECTION SURVEILLANCE SOLUTION MARKET SIZE, BY OUTBREAK MANAGEMENT, 2018-2030 (USD MILLION)
TABLE 131. PHILIPPINES INFECTION SURVEILLANCE SOLUTION MARKET SIZE, BY DEPLOYMENT, 2018-2030 (USD MILLION)
TABLE 132. PHILIPPINES INFECTION SURVEILLANCE SOLUTION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 133. SINGAPORE INFECTION SURVEILLANCE SOLUTION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 134. SINGAPORE INFECTION SURVEILLANCE SOLUTION MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 135. SINGAPORE INFECTION SURVEILLANCE SOLUTION MARKET SIZE, BY SOFTWARE, 2018-2030 (USD MILLION)
TABLE 136. SINGAPORE INFECTION SURVEILLANCE SOLUTION MARKET SIZE, BY INFECTION SURVEILLANCE, 2018-2030 (USD MILLION)
TABLE 137. SINGAPORE INFECTION SURVEILLANCE SOLUTION MARKET SIZE, BY OUTBREAK MANAGEMENT, 2018-2030 (USD MILLION)
TABLE 138. SINGAPORE INFECTION SURVEILLANCE SOLUTION MARKET SIZE, BY DEPLOYMENT, 2018-2030 (USD MILLION)
TABLE 139. SINGAPORE INFECTION SURVEILLANCE SOLUTION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 140. SOUTH KOREA INFECTION SURVEILLANCE SOLUTION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 141. SOUTH KOREA INFECTION SURVEILLANCE SOLUTION MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 142. SOUTH KOREA INFECTION SURVEILLANCE SOLUTION MARKET SIZE, BY SOFTWARE, 2018-2030 (USD MILLION)
TABLE 143. SOUTH KOREA INFECTION SURVEILLANCE SOLUTION MARKET SIZE, BY INFECTION SURVEILLANCE, 2018-2030 (USD MILLION)
TABLE 144. SOUTH KOREA INFECTION SURVEILLANCE SOLUTION MARKET SIZE, BY OUTBREAK MANAGEMENT, 2018-2030 (USD MILLION)
TABLE 145. SOUTH KOREA INFECTION SURVEILLANCE SOLUTION MARKET SIZE, BY DEPLOYMENT, 2018-2030 (USD MILLION)
TABLE 146. SOUTH KOREA INFECTION SURVEILLANCE SOLUTION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 147. TAIWAN INFECTION SURVEILLANCE SOLUTION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 148. TAIWAN INFECTION SURVEILLANCE SOLUTION MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 149. TAIWAN INFECTION SURVEILLANCE SOLUTION MARKET SIZE, BY SOFTWARE, 2018-2030 (USD MILLION)
TABLE 150. TAIWAN INFECTION SURVEILLANCE SOLUTION MARKET SIZE, BY INFECTION SURVEILLANCE, 2018-2030 (USD MILLION)
TABLE 151. TAIWAN INFECTION SURVEILLANCE SOLUTION MARKET SIZE, BY OUTBREAK MANAGEMENT, 2018-2030 (USD MILLION)
TABLE 152. TAIWAN INFECTION SURVEILLANCE SOLUTION MARKET SIZE, BY DEPLOYMENT, 2018-2030 (USD MILLION)
TABLE 153. TAIWAN INFECTION SURVEILLANCE SOLUTION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 154. THAILAND INFECTION SURVEILLANCE SOLUTION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 155. THAILAND INFECTION SURVEILLANCE SOLUTION MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 156. THAILAND INFECTION SURVEILLANCE SOLUTION MARKET SIZE, BY SOFTWARE, 2018-2030 (USD MILLION)
TABLE 157. THAILAND INFECTION SURVEILLANCE SOLUTION MARKET SIZE, BY INFECTION SURVEILLANCE, 2018-2030 (USD MILLION)
TABLE 158. THAILAND INFECTION SURVEILLANCE SOLUTION MARKET SIZE, BY OUTBREAK MANAGEMENT, 2018-2030 (USD MILLION)
TABLE 159. THAILAND INFECTION SURVEILLANCE SOLUTION MARKET SIZE, BY DEPLOYMENT, 2018-2030 (USD MILLION)
TABLE 160. THAILAND INFECTION SURVEILLANCE SOLUTION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 161. VIETNAM INFECTION SURVEILLANCE SOLUTION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 162. VIETNAM INFECTION SURVEILLANCE SOLUTION MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 163. VIETNAM INFECTION SURVEILLANCE SOLUTION MARKET SIZE, BY SOFTWARE, 2018-2030 (USD MILLION)
TABLE 164. VIETNAM INFECTION SURVEILLANCE SOLUTION MARKET SIZE, BY INFECTION SURVEILLANCE, 2018-2030 (USD MILLION)
TABLE 165. VIETNAM INFECTION SURVEILLANCE SOLUTION MARKET SIZE, BY OUTBREAK MANAGEMENT, 2018-2030 (USD MILLION)
TABLE 166. VIETNAM INFECTION SURVEILLANCE SOLUTION MARKET SIZE, BY DEPLOYMENT, 2018-2030 (USD MILLION)
TABLE 167. VIETNAM INFECTION SURVEILLANCE SOLUTION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 168. EUROPE, MIDDLE EAST & AFRICA INFECTION SURVEILLANCE SOLUTION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 169. EUROPE, MIDDLE EAST & AFRICA INFECTION SURVEILLANCE SOLUTION MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 170. EUROPE, MIDDLE EAST & AFRICA INFECTION SURVEILLANCE SOLUTION MARKET SIZE, BY SOFTWARE, 2018-2030 (USD MILLION)
TABLE 171. EUROPE, MIDDLE EAST & AFRICA INFECTION SURVEILLANCE SOLUTION MARKET SIZE, BY INFECTION SURVEILLANCE, 2018-2030 (USD MILLION)
TABLE 172. EUROPE, MIDDLE EAST & AFRICA INFECTION SURVEILLANCE SOLUTION MARKET SIZE, BY OUTBREAK MANAGEMENT, 2018-2030 (USD MILLION)
TABLE 173. EUROPE, MIDDLE EAST & AFRICA INFECTION SURVEILLANCE SOLUTION MARKET SIZE, BY DEPLOYMENT, 2018-2030 (USD MILLION)
TABLE 174. EUROPE, MIDDLE EAST & AFRICA INFECTION SURVEILLANCE SOLUTION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 175. EUROPE, MIDDLE EAST & AFRICA INFECTION SURVEILLANCE SOLUTION MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 176. DENMARK INFECTION SURVEILLANCE SOLUTION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 177. DENMARK INFECTION SURVEILLANCE SOLUTION MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 178. DENMARK INFECTION SURVEILLANCE SOLUTION MARKET SIZE, BY SOFTWARE, 2018-2030 (USD MILLION)
TABLE 179. DENMARK INFECTION SURVEILLANCE SOLUTION MARKET SIZE, BY INFECTION SURVEILLANCE, 2018-2030 (USD MILLION)
TABLE 180. DENMARK INFECTION SURVEILLANCE SOLUTION MARKET SIZE, BY OUTBREAK MANAGEMENT, 2018-2030 (USD MILLION)
TABLE 181. DENMARK INFECTION SURVEILLANCE SOLUTION MARKET SIZE, BY DEPLOYMENT, 2018-2030 (USD MILLION)
TABLE 182. DENMARK INFECTION SURVEILLANCE SOLUTION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 183. EGYPT INFECTION SURVEILLANCE SOLUTION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 184. EGYPT INFECTION SURVEILLANCE SOLUTION MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 185. EGYPT INFECTION SURVEILLANCE SOLUTION MARKET SIZE, BY SOFTWARE, 2018-2030 (USD MILLION)
TABLE 186. EGYPT INFECTION SURVEILLANCE SOLUTION MARKET SIZE, BY INFECTION SURVEILLANCE, 2018-2030 (USD MILLION)
TABLE 187. EGYPT INFECTION SURVEILLANCE SOLUTION MARKET SIZE, BY OUTBREAK MANAGEMENT, 2018-2030 (USD MILLION)
TABLE 188. EGYPT INFECTION SURVEILLANCE SOLUTION MARKET SIZE, BY DEPLOYMENT, 2018-2030 (USD MILLION)
TABLE 189. EGYPT INFECTION SURVEILLANCE SOLUTION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 190. FINLAND INFECTION SURVEILLANCE SOLUTION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 191. FINLAND INFECTION SURVEILLANCE SOLUTION MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 192. FINLAND INFECTION SURVEILLANCE SOLUTION MARKET SIZE, BY SOFTWARE, 2018-2030 (USD MILLION)
TABLE 193. FINLAND INFECTION SURVEILLANCE SOLUTION MARKET SIZE, BY INFECTION SURVEILLANCE, 2018-2030 (USD MILLION)
TABLE 194. FINLAND INFECTION SURVEILLANCE SOLUTION MARKET SIZE, BY OUTBREAK MANAGEMENT, 2018-2030 (USD MILLION)
TABLE 195. FINLAND INFECTION SURVEILLANCE SOLUTION MARKET SIZE, BY DEPLOYMENT, 2018-2030 (USD MILLION)
TABLE 196. FINLAND INFECTION SURVEILLANCE SOLUTION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 197. FRANCE INFECTION SURVEILLANCE SOLUTION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 198. FRANCE INFECTION SURVEILLANCE SOLUTION MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 199. FRANCE INFECTION SURVEILLANCE SOLUTION MARKET SIZE, BY SOFTWARE, 2018-2030 (USD MILLION)
TABLE 200. FRANCE INFECTION SURVEILLANCE SOLUTION MARKET SIZE, BY INFECTION SURVEILLANCE, 2018-2030 (USD MILLION)
TABLE 201. FRANCE INFECTION SURVEILLANCE SOLUTION MARKET SIZE, BY OUTBREAK MANAGEMENT, 2018-2030 (USD MILLION)
TABLE 202. FRANCE INFECTION SURVEILLANCE SOLUTION MARKET SIZE, BY DEPLOYMENT, 2018-2030 (USD MILLION)
TABLE 203. FRANCE INFECTION SURVEILLANCE SOLUTION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 204. GERMANY INFECTION SURVEILLANCE SOLUTION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 205. GERMANY INFECTION SURVEILLANCE SOLUTION MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 206. GERMANY INFECTION SURVEILLANCE SOLUTION MARKET SIZE, BY SOFTWARE, 2018-2030 (USD MILLION)
TABLE 207. GERMANY INFECTION SURVEILLANCE SOLUTION MARKET SIZE, BY INFECTION SURVEILLANCE, 2018-2030 (USD MILLION)
TABLE 208. GERMANY INFECTION SURVEILLANCE SOLUTION MARKET SIZE, BY OUTBREAK MANAGEMENT, 2018-2030 (USD MILLION)
TABLE 209. GERMANY INFECTION SURVEILLANCE SOLUTION MARKET SIZE, BY DEPLOYMENT, 2018-2030 (USD MILLION)
TABLE 210. GERMANY INFECTION SURVEILLANCE SOLUTION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 211. ISRAEL INFECTION SURVEILLANCE SOLUTION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 212. ISRAEL INFECTION SURVEILLANCE SOLUTION MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 213. ISRAEL INFECTION SURVEILLANCE SOLUTION MARKET SIZE, BY SOFTWARE, 2018-2030 (USD MILLION)
TABLE 214. ISRAEL INFECTION SURVEILLANCE SOLUTION MARKET SIZE, BY INFECTION SURVEILLANCE, 2018-2030 (USD MILLION)
TABLE 215. ISRAEL INFECTION SURVEILLANCE SOLUTION MARKET SIZE, BY OUTBREAK MANAGEMENT, 2018-2030 (USD MILLION)
TABLE 216. ISRAEL INFECTION SURVEILLANCE SOLUTION MARKET SIZE, BY DEPLOYMENT, 2018-2030 (USD MILLION)
TABLE 217. ISRAEL INFECTION SURVEILLANCE SOLUTION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 218. ITALY INFECTION SURVEILLANCE SOLUTION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 219. ITALY INFECTION SURVEILLANCE SOLUTION MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 220. ITALY INFECTION SURVEILLANCE SOLUTION MARKET SIZE, BY SOFTWARE, 2018-2030 (USD MILLION)
TABLE 221. ITALY INFECTION SURVEILLANCE SOLUTION MARKET SIZE, BY INFECTION SURVEILLANCE, 2018-2030 (USD MILLION)
TABLE 222. ITALY INFECTION SURVEILLANCE SOLUTION MARKET SIZE, BY OUTBREAK MANAGEMENT, 2018-2030 (USD MILLION)
TABLE 223. ITALY INFECTION SURVEILLANCE SOLUTION MARKET SIZE, BY DEPLOYMENT, 2018-2030 (USD MILLION)
TABLE 224. ITALY INFECTION SURVEILLANCE SOLUTION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 225. NETHERLANDS INFECTION SURVEILLANCE SOLUTION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 226. NETHERLANDS INFECTION SURVEILLANCE SOLUTION MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 227. NETHERLANDS INFECTION SURVEILLANCE SOLUTION MARKET SIZE, BY SOFTWARE, 2018-2030 (USD MILLION)
TABLE 228. NETHERLANDS INFECTION SURVEILLANCE SOLUTION MARKET SIZE, BY INFECTION SURVEILLANCE, 2018-2030 (USD MILLION)
TABLE 229. NETHERLANDS INFECTION SURVEILLANCE SOLUTION MARKET SIZE, BY OUTBREAK MANAGEMENT, 2018-2030 (USD MILLION)
TABLE 230. NETHERLANDS INFECTION SURVEILLANCE SOLUTION MARKET SIZE, BY DEPLOYMENT, 2018-2030 (USD MILLION)
TABLE 231. NETHERLANDS INFECTION SURVEILLANCE SOLUTION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 232. NIGERIA INFECTION SURVEILLANCE SOLUTION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 233. NIGERIA INFECTION SURVEILLANCE SOLUTION MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 234. NIGERIA INFECTION SURVEILLANCE SOLUTION MARKET SIZE, BY SOFTWARE, 2018-2030 (USD MILLION)
TABLE 235. NIGERIA INFECTION SURVEILLANCE SOLUTION MARKET SIZE, BY INFECTION SURVEILLANCE, 2018-2030 (USD MILLION)
TABLE 236. NIGERIA INFECTION SURVEILLANCE SOLUTION MARKET SIZE, BY OUTBREAK MANAGEMENT, 2018-2030 (USD MILLION)
TABLE 237. NIGERIA INFECTION SURVEILLANCE SOLUTION MARKET SIZE, BY DEPLOYMENT, 2018-2030 (USD MILLION)
TABLE 238. NIGERIA INFECTION SURVEILLANCE SOLUTION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 239. NORWAY INFECTION SURVEILLANCE SOLUTION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 240. NORWAY INFECTION SURVEILLANCE SOLUTION MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 241. NORWAY INFECTION SURVEILLANCE SOLUTION MARKET SIZE, BY SOFTWARE, 2018-2030 (USD MILLION)
TABLE 242. NORWAY INFECTION SURVEILLANCE SOLUTION MARKET SIZE, BY INFECTION SURVEILLANCE, 2018-2030 (USD MILLION)
TABLE 243. NORWAY INFECTION SURVEILLANCE SOLUTION MARKET SIZE, BY OUTBREAK MANAGEMENT, 2018-2030 (USD MILLION)
TABLE 244. NORWAY INFECTION SURVEILLANCE SOLUTION MARKET SIZE, BY DEPLOYMENT, 2018-2030 (USD MILLION)
TABLE 245. NORWAY INFECTION SURVEILLANCE SOLUTION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 246. POLAND INFECTION SURVEILLANCE SOLUTION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 247. POLAND INFECTION SURVEILLANCE SOLUTION MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 248. POLAND INFECTION SURVEILLANCE SOLUTION MARKET SIZE, BY SOFTWARE, 2018-2030 (USD MILLION)
TABLE 249. POLAND INFECTION SURVEILLANCE SOLUTION MARKET SIZE, BY INFECTION SURVEILLANCE, 2018-2030 (USD MILLION)
TABLE 250. POLAND INFECTION SURVEILLANCE SOLUTION MARKET SIZE, BY OUTBREAK MANAGEMENT, 2018-2030 (USD MILLION)
TABLE 251. POLAND INFECTION SURVEILLANCE SOLUTION MARKET SIZE, BY DEPLOYMENT, 2018-2030 (USD MILLION)
TABLE 252. POLAND INFECTION SURVEILLANCE SOLUTION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 253. QATAR INFECTION SURVEILLANCE SOLUTION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 254. QATAR INFECTION SURVEILLANCE SOLUTION MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 255. QATAR INFECTION SURVEILLANCE SOLUTION MARKET SIZE, BY SOFTWARE, 2018-2030 (USD MILLION)
TABLE 256. QATAR INFECTION SURVEILLANCE SOLUTION MARKET SIZE, BY INFECTION SURVEILLANCE, 2018-2030 (USD MILLION)
TABLE 257. QATAR INFECTION SURVEILLANCE SOLUTION MARKET SIZE, BY OUTBREAK MANAGEMENT, 2018-2030 (USD MILLION)
TABLE 258. QATAR INFECTION SURVEILLANCE SOLUTION MARKET SIZE, BY DEPLOYMENT, 2018-2030 (USD MILLION)
TABLE 259. QATAR INFECTION SURVEILLANCE SOLUTION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 260. RUSSIA INFECTION SURVEILLANCE SOLUTION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 261. RUSSIA INFECTION SURVEILLANCE SOLUTION MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 262. RUSSIA INFECTION SURVEILLANCE SOLUTION MARKET SIZE, BY SOFTWARE, 2018-2030 (USD MILLION)
TABLE 263. RUSSIA INFECTION SURVEILLANCE SOLUTION MARKET SIZE, BY INFECTION SURVEILLANCE, 2018-2030 (USD MILLION)
TABLE 264. RUSSIA INFECTION SURVEILLANCE SOLUTION MARKET SIZE, BY OUTBREAK MANAGEMENT, 2018-2030 (USD MILLION)
TABLE 265. RUSSIA INFECTION SURVEILLANCE SOLUTION MARKET SIZE, BY DEPLOYMENT, 2018-2030 (USD MILLION)
TABLE 266. RUSSIA INFECTION SURVEILLANCE SOLUTION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 267. SAUDI ARABIA INFECTION SURVEILLANCE SOLUTION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 268. SAUDI ARABIA INFECTION SURVEILLANCE SOLUTION MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 269. SAUDI ARABIA INFECTION SURVEILLANCE SOLUTION MARKET SIZE, BY SOFTWARE, 2018-2030 (USD MILLION)
TABLE 270. SAUDI ARABIA INFECTION SURVEILLANCE SOLUTION MARKET SIZE, BY INFECTION SURVEILLANCE, 2018-2030 (USD MILLION)
TABLE 271. SAUDI ARABIA INFECTION SURVEILLANCE SOLUTION MARKET SIZE, BY OUTBREAK MANAGEMENT, 2018-2030 (USD MILLION)
TABLE 272. SAUDI ARABIA INFECTION SURVEILLANCE SOLUTION MARKET SIZE, BY DEPLOYMENT, 2018-2030 (USD MILLION)
TABLE 273. SAUDI ARABIA INFECTION SURVEILLANCE SOLUTION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 274. SOUTH AFRICA INFECTION SURVEILLANCE SOLUTION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 275. SOUTH AFRICA INFECTION SURVEILLANCE SOLUTION MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 276. SOUTH AFRICA INFECTION SURVEILLANCE SOLUTION MARKET SIZE, BY SOFTWARE, 2018-2030 (USD MILLION)
TABLE 277. SOUTH AFRICA INFECTION SURVEILLANCE SOLUTION MARKET SIZE, BY INFECTION SURVEILLANCE, 2018-2030 (USD MILLION)
TABLE 278. SOUTH AFRICA INFECTION SURVEILLANCE SOLUTION MARKET SIZE, BY OUTBREAK MANAGEMENT, 2018-2030 (USD MILLION)
TABLE 279. SOUTH AFRICA INFECTION SURVEILLANCE SOLUTION MARKET SIZE, BY DEPLOYMENT, 2018-2030 (USD MILLION)
TABLE 280. SOUTH AFRICA INFECTION SURVEILLANCE SOLUTION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 281. SPAIN INFECTION SURVEILLANCE SOLUTION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 282. SPAIN INFECTION SURVEILLANCE SOLUTION MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 283. SPAIN INFECTION SURVEILLANCE SOLUTION MARKET SIZE, BY SOFTWARE, 2018-2030 (USD MILLION)
TABLE 284. SPAIN INFECTION SURVEILLANCE SOLUTION MARKET SIZE, BY INFECTION SURVEILLANCE, 2018-2030 (USD MILLION)
TABLE 285. SPAIN INFECTION SURVEILLANCE SOLUTION MARKET SIZE, BY OUTBREAK MANAGEMENT, 2018-2030 (USD MILLION)
TABLE 286. SPAIN INFECTION SURVEILLANCE SOLUTION MARKET SIZE, BY DEPLOYMENT, 2018-2030 (USD MILLION)
TABLE 287. SPAIN INFECTION SURVEILLANCE SOLUTION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 288. SWEDEN INFECTION SURVEILLANCE SOLUTION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 289. SWEDEN INFECTION SURVEILLANCE SOLUTION MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 290. SWEDEN INFECTION SURVEILLANCE SOLUTION MARKET SIZE, BY SOFTWARE, 2018-2030 (USD MILLION)
TABLE 291. SWEDEN INFECTION SURVEILLANCE SOLUTION MARKET SIZE, BY INFECTION SURVEILLANCE, 2018-2030 (USD MILLION)
TABLE 292. SWEDEN INFECTION SURVEILLANCE SOLUTION MARKET SIZE, BY OUTBREAK MANAGEMENT, 2018-2030 (USD MILLION)
TABLE 293. SWEDEN INFECTION SURVEILLANCE SOLUTION MARKET SIZE, BY DEPLOYMENT, 2018-2030 (USD MILLION)
TABLE 294. SWEDEN INFECTION SURVEILLANCE SOLUTION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 295. SWITZERLAND INFECTION SURVEILLANCE SOLUTION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 296. SWITZERLAND INFECTION SURVEILLANCE SOLUTION MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 297. SWITZERLAND INFECTION SURVEILLANCE SOLUTION MARKET SIZE, BY SOFTWARE, 2018-2030 (USD MILLION)
TABLE 298. SWITZERLAND INFECTION SURVEILLANCE SOLUTION MARKET SIZE, BY INFECTION SURVEILLANCE, 2018-2030 (USD MILLION)
TABLE 299. SWITZERLAND INFECTION SURVEILLANCE SOLUTION MARKET SIZE, BY OUTBREAK MANAGEMENT, 2018-2030 (USD MILLION)
TABLE 300. SWITZERLAND INFECTION SURVEILLANCE SOLUTION MARKET SIZE, BY DEPLOYMENT, 2018-2030 (USD MILLION)
TABLE 301. SWITZERLAND INFECTION SURVEILLANCE SOLUTION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 302. TURKEY INFECTION SURVEILLANCE SOLUTION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 303. TURKEY INFECTION SURVEILLANCE SOLUTION MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 304. TURKEY INFECTION SURVEILLANCE SOLUTION MARKET SIZE, BY SOFTWARE, 2018-2030 (USD MILLION)
TABLE 305. TURKEY INFECTION SURVEILLANCE SOLUTION MARKET SIZE, BY INFECTION SURVEILLANCE, 2018-2030 (USD MILLION)
TABLE 306. TURKEY INFECTION SURVEILLANCE SOLUTION MARKET SIZE, BY OUTBREAK MANAGEMENT, 2018-2030 (USD MILLION)
TABLE 307. TURKEY INFECTION SURVEILLANCE SOLUTION MARKET SIZE, BY DEPLOYMENT, 2018-2030 (USD MILLION)
TABLE 308. TURKEY INFECTION SURVEILLANCE SOLUTION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 309. UNITED ARAB EMIRATES INFECTION SURVEILLANCE SOLUTION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TA

Companies Mentioned

The leading players in the Infection Surveillance Solution Market, which are profiled in this report, include:
  • 3M Company
  • Altarum
  • Baxter International, Inc.
  • Becton, Dickinson and Company
  • bioMérieux SA
  • BioVigil Healthcare Systems, Inc.
  • Cardinal Health Inc.
  • CenTrak, Inc.
  • Clinsys, Inc.
  • Conduent, Inc.
  • Datlowe, s.r.o.
  • DNV AS
  • Ecolab Inc.
  • Gunnebo Entrance Control Ltd.
  • Health Matrix.
  • Ibhar Technologies Pvt Ltd
  • Inovalon
  • International Business Machines Corporation
  • Medexter Healthcare GmbH
  • Oracle Corporation
  • PointClickCare
  • Premier Inc.
  • RLDatix
  • Securitas Healthcare, LLC.
  • Strategic Solutions Group
  • Thermo Fisher Scientific Inc.
  • Vecna Technologies, Inc.
  • VigiLanz Corporation
  • Vitalacy Inc.
  • Vizzia Technologies
  • Wolters Kluwer N.V.

Methodology

Loading
LOADING...

Table Information